Please use this identifier to cite or link to this item:
|Title:||ABO blood group and related antigens, natural antibodies and transplantation.||Austin Authors:||Milland, Julie;Sandrin, Mauro S||Affiliation:||Department of Surgery (Austin Health), University of Melbourne, Box 5555, Heidelberg 3084, Australia||Issue Date:||1-Dec-2006||Publication information:||Tissue Antigens; 68(6): 459-66||Abstract:||The current success rate of transplant surgery and immunosuppression has led to a demand for organs that has outstripped the supply. This has required investigation of alternate strategies. Therefore, allotransplantation across the ABO blood group barrier has commenced, and pig-to-human xenotransplantation is under consideration. The first immunological barrier to both these types of transplantation is the prevention of the antibody-mediated rejection. This rejection is a result of natural preformed antibodies circulating in the serum of the recipient binding to either ABO (for allo) or alpha-galactose (alpha-Gal) (for xeno) antigens expressed on the donor tissue. These antibodies recognise antigens that are, in both cases, carbohydrate molecules with the characteristic feature that the nonreducing terminal carbohydrate is either a Gal or N-acetlygalactosamine residue in an alpha1,3 linkage. These epitopes are synthesised by closely related members of a single family of glycosyltransferases. This review discusses the carbohydrate antigens, the enzymes involved in their synthesis and the consequences of natural antibodies binding these antigens.||Gov't Doc #:||17176435||URI:||http://ahro.austin.org.au/austinjspui/handle/1/10289||DOI:||10.1111/j.1399-0039.2006.00721.x||URL:||https://pubmed.ncbi.nlm.nih.gov/17176435||Type:||Journal Article||Subjects:||ABO Blood-Group System.chemistry.immunology
Amino Acid Sequence
Molecular Sequence Data
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 2, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.